Short Interest in Prenetics Global Limited (NASDAQ:PRENW) Declines By 14.7%

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant decline in short interest during the month of February. As of February 13th, there was short interest totaling 1,740 shares, a decline of 14.7% from the January 29th total of 2,040 shares. Based on an average daily volume of 2,725 shares, the short-interest ratio is presently 0.6 days. Based on an average daily volume of 2,725 shares, the short-interest ratio is presently 0.6 days.

Prenetics Global Stock Performance

Shares of Prenetics Global stock remained flat at $0.02 during trading on Wednesday. The stock had a trading volume of 6,300 shares, compared to its average volume of 10,594. Prenetics Global has a 12-month low of $0.01 and a 12-month high of $0.07. The business has a 50 day simple moving average of $0.03 and a two-hundred day simple moving average of $0.03.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.